In our comparison of PT-NASH to NT-NASH, we identified dysregulation of the PI3K-Akt signaling pathway, which has been associated with metabolic dysfunction, including obesity, metabolic syndrome, and NAFLD (16). The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.